s6y

Ayala Pharmaceuticals, Inc.

CIK
1100397
Industry
Pharmaceutical Preparations
Formerly
Advaxis, Inc., GREAT EXPECTATIONS & ASSOCIATES INC

Financials 92

  1. 10-K/A Annual Report for period ending Dec 31, 2023
  2. 10-K Annual Report for period ending Dec 31, 2023
  3. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Apr 1, 2024
  4. 10-Q Quarterly Report for period ending Sep 30, 2023
  5. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Nov 14, 2023
  6. 10-Q Quarterly Report for period ending Jun 30, 2023
  7. 10-Q Quarterly Report for period ending Mar 31, 2023
  8. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Mar 31, 2023
  9. 10-K Annual Report for period ending Oct 31, 2022
  10. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Oct 31, 2022

All 92 financials filings

News 283

  1. 8-K/A Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K/A Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 283 news filings

Ownership 549

  1. 4 Statement of changes in beneficial ownership of securities
  2. SC 13G/A Major Shareholders
  3. 4 Statement of changes in beneficial ownership of securities
  4. SC 13D/A Major Shareholders
  5. SC 13G/A Major Shareholders
  6. 4 Statement of changes in beneficial ownership of securities
  7. SC 13D/A Major Shareholders
  8. 3 Initial statement of beneficial ownership of securities
  9. 3/A Initial statement of beneficial ownership of securities
  10. 3/A Initial statement of beneficial ownership of securities

All 549 ownership filings

Prospectus 156

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. S-8 POS Post-effective amendment to a S-8 registration statement
  5. S-8 POS Post-effective amendment to a S-8 registration statement
  6. S-8 POS Post-effective amendment to a S-8 registration statement
  7. S-8 POS Post-effective amendment to a S-8 registration statement
  8. S-8 POS Post-effective amendment to a S-8 registration statement
  9. S-8 POS Post-effective amendment to a S-8 registration statement
  10. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

All 156 prospectus filings

Proxies 65

  1. DEFM14C Definitive information statement relating to merger or acquisition
  2. PREM14C Preliminary information statements relating to merger or acquisition
  3. DEF 14A Definitive proxy statements
  4. DEF 14A Definitive proxy statements
  5. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  6. DEF 14A Definitive proxy statements
  7. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  8. DEF 14A Definitive proxy statements
  9. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  10. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

All 65 proxies filings

Other 185

  1. SCHEDULE 13G
  2. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  3. D Exempt (Private) Offering
  4. EFFECT Notice of Effectiveness
  5. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  6. UPLOAD Letter (PDF)
  7. D Exempt (Private) Offering
  8. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  9. EFFECT Notice of Effectiveness
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 185 other filings